Kenji Kuroda Selected Research

1- (((alpha- isobutanoyloxyethoxy)carbonyl)aminomethyl)- 1- cyclohexaneacetic acid

1/2013	Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
3/2012	Long-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenji Kuroda Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 12/2003
13	Stomach Neoplasms (Stomach Cancer) 06/2022 - 11/2013
12	Carcinoma (Carcinomatosis) 05/2021 - 01/2012
9	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2003
7	Lymphatic Metastasis 05/2021 - 05/2008
7	Renal Cell Carcinoma (Grawitz Tumor) 10/2017 - 07/2009
6	Narcolepsy 04/2022 - 11/2006
6	Restless Legs Syndrome (Restless Legs) 09/2013 - 01/2010
5	Neoplasm Metastasis (Metastasis) 01/2019 - 05/2008
5	Schizophrenia (Dementia Praecox) 01/2018 - 06/2012
4	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 02/2017
4	Cataplexy 12/2018 - 11/2006
3	Inflammation (Inflammations) 01/2022 - 01/2018
3	Urinary Bladder Neoplasms (Bladder Cancer) 05/2021 - 12/2003
3	Hydronephrosis 05/2021 - 05/2011
3	Hemorrhage 01/2021 - 05/2011
2	Idiopathic Hypersomnia 04/2022 - 01/2015
2	Nausea 12/2021 - 07/2019
2	Rectal Neoplasms (Rectal Cancer) 12/2021 - 11/2015
2	Non-Muscle Invasive Bladder Neoplasms 05/2021 - 09/2020
2	Urethral Stricture 01/2021 - 05/2011
2	Margins of Excision 04/2020 - 05/2019
2	Carcinogenesis 04/2020 - 01/2015
2	Abdominal Pain (Pain, Abdominal) 04/2019 - 11/2013
2	Disorders of Excessive Somnolence (Hypersomnia) 12/2018 - 02/2015
2	Mood Disorders (Mood Disorder) 01/2018 - 06/2012
2	Major Depressive Disorder (Major Depressive Disorders) 01/2018 - 01/2018
2	Kidney Neoplasms (Kidney Cancer) 07/2017 - 07/2009
2	Thrombosis (Thrombus) 01/2015 - 06/2011
2	Necrosis 01/2015 - 08/2011
2	Body Weight (Weight, Body) 10/2012 - 08/2005
2	Cachexia 01/2007 - 08/2005
1	Abscess 04/2022
1	Cholangiocarcinoma 01/2022
1	Rupture 01/2022
1	Pathologic Constriction (Stenosis) 12/2021
1	Dropped Head Syndrome 05/2021
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2021
1	Clinical Deterioration 01/2021
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 01/2021

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 05/2021 - 09/2013
5	C-Reactive ProteinIBA 01/2022 - 08/2011
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2017
4	Pramipexole (Mirapex)FDA LinkGeneric 09/2013 - 01/2010
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2005
3	AlbuminsIBA 03/2021 - 08/2005
3	AntigensIBA 01/2019 - 10/2009
3	HLA-DQB1 antigen (HLA DQB1)IBA 12/2018 - 01/2015
3	HLA Antigens (Human Leukocyte Antigens)IBA 12/2018 - 02/2015
3	CytokinesIBA 01/2018 - 12/2003
3	ParaffinIBA 01/2015 - 01/2011
3	NF-kappa B (NF-kB)IBA 08/2005 - 01/2003
2	OrexinsIBA 04/2022 - 11/2006
2	CXC ChemokinesIBA 01/2022 - 12/2019
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2019
2	p21-Activated KinasesIBA 04/2020 - 01/2015
2	Keratins (Keratin)IBA 01/2020 - 01/2019
2	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 10/2009
2	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 07/2014
2	Formaldehyde (Formol)FDA Link 01/2015 - 01/2011
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 05/2014 - 01/2014
2	1- (((alpha- isobutanoyloxyethoxy)carbonyl)aminomethyl)- 1- cyclohexaneacetic acidIBA 01/2013 - 03/2012
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2012 - 10/2009
2	Proteins (Proteins, Gene)FDA Link 01/2011 - 01/2007
2	dehydroxymethylepoxyquinomicinIBA 08/2005 - 01/2003
2	Hormones (Hormone)IBA 08/2005 - 01/2003
1	Minocycline (Cyclops)FDA LinkGeneric 04/2022
1	Lipocalin-2IBA 01/2022
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 08/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 05/2021
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 05/2021
1	Fibrinogen (Factor I)FDA Link 05/2021
1	Annexin A2 (Annexin II)IBA 05/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2021
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2021
1	Carcinoembryonic AntigenIBA 01/2021
1	Epithelial Cell Adhesion MoleculeIBA 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2020
1	Phosphotransferases (Kinase)IBA 11/2020

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 05/2021 - 11/2013
5	Therapeutics 05/2021 - 09/2010
5	Nephroureterectomy 05/2019 - 01/2012
4	Catheters 04/2022 - 05/2011
4	Nephrectomy 01/2019 - 06/2011
3	Gastrectomy 06/2022 - 12/2021
3	Lymph Node Excision (Lymph Node Dissection) 01/2017 - 04/2013
3	Prostatectomy (Retropubic Prostatectomy) 12/2013 - 07/2008
2	Neoadjuvant Therapy 12/2021 - 01/2012
2	Adjuvant Chemotherapy 12/2021 - 01/2015
2	Transurethral Resection of Bladder 05/2021 - 09/2020
2	Radiofrequency Ablation 07/2017 - 01/2017
1	Colostomy 12/2021
1	Intravesical Administration 05/2021
1	Cystectomy 03/2021
1	Punctures 01/2021
1	Cannula 01/2021
1	Cystostomy (Suprapubic Cystostomy) 01/2021